Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
12/12/2007 | EP1863535A1 Endoparasiticide |
12/12/2007 | EP1863533A1 Combination of interleukin-6 antagonists and antiproliferative drugs |
12/12/2007 | EP1863525A2 Polypeptides |
12/12/2007 | EP1863524A1 Methods and compositions for the treatment of cancer |
12/12/2007 | EP1863523A1 Use of the mst protein for the treatment of a thromboembolic disorder |
12/12/2007 | EP1863521A1 Extended glp-1 compounds |
12/12/2007 | EP1863520A1 Use of interleukin 17e for the treatment of cancer |
12/12/2007 | EP1863519A1 Monitoring and modulating hgf/hgfr activity |
12/12/2007 | EP1863518A2 Methods for stimulating hair growth by administering bmps |
12/12/2007 | EP1863517A2 Use of fibrous tissue inducing proteins for hernia repair |
12/12/2007 | EP1863516A2 Compositions and methods involving mda-7 for the treatment of cancer |
12/12/2007 | EP1863515A2 Composition containing beta-defensin 2 |
12/12/2007 | EP1863514A2 Therapeutic use of scin, a staphylococcal complement inhibitor in inflammatory diseases |
12/12/2007 | EP1863513A2 Potent and specific immunoproteasome inhibitors |
12/12/2007 | EP1863512A1 Enhancing myc-dependent sensitivity of cancer to dr5 agonists |
12/12/2007 | EP1863511A2 Alkyl-glycoside enhanced vaccination |
12/12/2007 | EP1863510A1 Methods for treating parkinson's disease |
12/12/2007 | EP1863503A2 Composition and methods for delivering carbon monoxide (co) and nitric ozide (no) co to tissue using heme proteins as carriers |
12/12/2007 | EP1863348A1 Cell permeabilization and stabilization reagent and method of use |
12/12/2007 | EP1773378B1 Use of botulinum toxin for the preparation of a medicament for the treatment of lithiasis of salivary gland, gall bladder, kidney, or pancreas |
12/12/2007 | EP1735335A4 Cell-killing peptide |
12/12/2007 | EP1644403B1 Cytotoxic depsipeptides |
12/12/2007 | EP1496933A4 Use of interleukin-19 to treat ovarian cancer |
12/12/2007 | EP1490492B1 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
12/12/2007 | EP1432803B1 Fragments of the human zn-alpha2-glycoprotein and their use in methods of treatment of obesity |
12/12/2007 | EP1355668B1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease |
12/12/2007 | EP1309618B1 Leucine-based motif and clostridial neurotoxins |
12/12/2007 | EP1268481B1 Kinase inhibitors as therapeutic agents |
12/12/2007 | EP1255456B1 Use of glutamate or of glutamic acid for the prevention of hyperpermeability or undesired permeability of the intestinal wall |
12/12/2007 | EP1237912B1 Five-helix protein |
12/12/2007 | EP1180119B1 Recombinant haemophilus influenzae adhesin proteins |
12/12/2007 | EP1148779B1 Expression of secreted human alpha-fetoprotein in transgenic animals |
12/12/2007 | EP1144454B1 Modified peptides as therapeutic agents |
12/12/2007 | EP1137792B9 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
12/12/2007 | EP1135177B2 Porous composite matrix and the production and use thereof |
12/12/2007 | EP1107988B1 Method for chromatographically purifying insulins |
12/12/2007 | EP1000144B1 Lactoferrin receptor gene of moraxella |
12/12/2007 | EP0932606B1 Inhibitors of prenyl transferases |
12/12/2007 | EP0894130B1 Modulators of tnf receptor associated factor (traf), their preparation and use |
12/12/2007 | EP0888377B1 MURINE alpha(1,3)-FUCOSYLTRANSFERASE (Fuc-TVII) |
12/12/2007 | EP0769967B1 Conjugates comprising an antitumour agent and their use |
12/12/2007 | EP0723555B1 Chimeric proteins which block complement activation |
12/12/2007 | CN101087889A Biomarkers for breast cancer |
12/12/2007 | CN101087805A Method for purifying FSH |
12/12/2007 | CN101087619A Method of treatment or prophylaxis |
12/12/2007 | CN101087618A Leuprolide acetate and acetylcholinesterase inhibitors or NMDA receptor antagonists for the treatment of alzheimer's disease |
12/12/2007 | CN101087592A Process for the manufacture of sterile suspensions or lyophilisates of low-soluble basic peptide complexes, pharmaceutical formulations comprising these complexes and their use as medicament |
12/12/2007 | CN101086007A Manyzoned polypore glycopeptide production method and its formulation |
12/12/2007 | CN101085813A Soluble TNF acceptor mutant |
12/12/2007 | CN101085809A Batifeiban and synthetic and preparing technique for analogue thereof |
12/12/2007 | CN101085806A Synthetic way and use of product thereof |
12/12/2007 | CN101085363A Application of liver cell growth factor gene |
12/12/2007 | CN101085346A Attenuated pestiviruses |
12/12/2007 | CN101085345A High mannose proteins and methods of making high mannose proteins |
12/12/2007 | CN101085344A Biological medicare medicine for protecting enzyme activity and removing free radical, and preparing method thereof |
12/12/2007 | CN101085343A SOD health care composition |
12/12/2007 | CN101085342A Method of detecting rhCNTF medicament activity by normal rat weight loss method |
12/12/2007 | CN101085341A Eye implanted gel containing cyclosporin |
12/12/2007 | CN100354426C Viral core protein-cationic lipid-nucleic acid-delivery complexes |
12/12/2007 | CN100354425C Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines |
12/12/2007 | CN100354307C NOGO receptor-mediated blockade of axonal growth |
12/12/2007 | CN100354306C GLP-1 derivatives and transmicosal absorption preparations thereof |
12/12/2007 | CN100354305C Mage-A1 peptides presented by HLA class II molecules |
12/12/2007 | CN100354003C Sodium acetylide/ soybean separation protein commixed gel granule preparation method |
12/12/2007 | CN100354000C Use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia |
12/12/2007 | CN100353999C Pharmaceutical compositions of fibrinolytic agent |
12/12/2007 | CN100353998C Application of combination of cytokine and hypoglycemic in treatment of diabetes |
12/12/2007 | CN100353997C Stabilized preparation containing protein |
12/11/2007 | US7307161 Human Gil-19/AE289 polynucleotides |
12/11/2007 | US7307160 OtsA gene encoding trehalose-6-phosphate synthase from a coryneform bacterium |
12/11/2007 | US7307154 DNA encoding a novel RG1 polypeptide |
12/11/2007 | US7307150 Dextran-hemoglobin conjugates as blood substitutes |
12/11/2007 | US7307147 Latent fusion protein |
12/11/2007 | US7307143 Conductin protein and a related agent for diagnosing and treating tumor illnesses |
12/11/2007 | US7307142 Leptin antagonists |
12/11/2007 | US7307101 Administering N-hydroxy-N-(4-butyl-2-methylphenyl)-formamidine (HET0016) to increase or prevent a decrease in cerebral blood flow |
12/11/2007 | US7307069 Inflammatory diseases and cancers; promotion of apoptosis; may have phosphorothioate, 2'-O-(2-methoxyethyl) sugar, and/or 5-methyl cytosine modifications; useful prophylactically, and as clinical research and diagnostic tools. |
12/11/2007 | US7307066 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
12/11/2007 | US7307065 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents |
12/11/2007 | US7307064 Methods for treating cardiovascular disease using a soluble CTLA4 molecule |
12/11/2007 | US7307063 Melanocortin metallopeptides for treatment of sexual dysfunction |
12/11/2007 | US7307062 such as anxiety disorder, attention deficit/hyperactivity disorder, autistic disorder, bipolar disorder, major depression, mood disorder, pervasive developmental disorder, psychotic disorder and schizophrenia by administering an antimicrobial composition optionally with a probiotic mixture |
12/11/2007 | US7307061 N-substituted with benzyl, isobutyl, dimethylaminopropyl, aminoethyl or aminobutyl and capped with lysine on one end and acetylated on the other; pharmaceutical, healthcare, medical device, industrial, food, agricultural, and personal care applications |
12/11/2007 | US7307060 Administering a vascular endothelial growth factor (VEGF120, VEGF188 or VEGF165); intra-uterine or intra-amniotically to a fetus; intra-tracheal to a neonate |
12/11/2007 | US7307059 isolated, labeled peptides or proteins produced by administering labeled water wherein the isotope is incorporated into the peptides or proteins via metabolic synthesis, then isolated |
12/11/2007 | US7307058 Multimeric Apo A-I agonist compounds |
12/11/2007 | US7307057 Lantibiotics isolated from Microbispora sp. ATCC PTA-5024; activity against Gram-positive bacteria including methicillin and vancomycin resistant strains, and some Gram-negative bacteria such as M. catharralis, Neisseria species and H. influenzae and Mycobacteria. |
12/11/2007 | US7306927 Diagnosing cancer in humans; obtain sample, detect expression of chymotrypsin, presence of chymotrypsin enzyme indicates cancer |
12/11/2007 | US7306922 Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof |
12/11/2007 | US7306920 Gene associated with regulation of energy balance, obesity and diabetes and uses therefor |
12/11/2007 | US7306908 Mutant Dna; transcription of genomes |
12/11/2007 | US7306907 Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
12/11/2007 | US7306903 Use of test cells comprising DNA defining a morphogen-responsive transcription activating element operatively associated with reporter gene, increase in expression of detectable gene product after exposing test cell to candidate compound indicates ability of compound to induce morphogen-mediated effect |
12/11/2007 | US7306808 Orientia tsutsugamushi truncated recombinant outer membrane protein (r47) and (r57) vaccines diagnostics and therapeutics for scrub typhus |
12/11/2007 | US7306804 HIV-specific T-cell induction |
12/11/2007 | US7306803 Methods for modulating angiogenesis |
12/11/2007 | US7306801 Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein |
12/11/2007 | US7306799 Use of fusion polypeptides capable of binding vascular endothelial cell growth factor (VEGF), VEGF family members, and splice variants with specifically desirable characteristics; therapy for ocular diseases |
12/11/2007 | US7306797 Use of a compound antagonist of ESM-1 protein for producing a medicine for treating cancer |
12/11/2007 | US7306796 13-transmembrane protein expressed in prostate cancer |